Alden Doyle

1.5k total citations
51 papers, 1.0k citations indexed

About

Alden Doyle is a scholar working on Transplantation, Epidemiology and Surgery. According to data from OpenAlex, Alden Doyle has authored 51 papers receiving a total of 1.0k indexed citations (citations by other indexed papers that have themselves been cited), including 20 papers in Transplantation, 18 papers in Epidemiology and 15 papers in Surgery. Recurrent topics in Alden Doyle's work include Renal Transplantation Outcomes and Treatments (19 papers), Nonmelanoma Skin Cancer Studies (7 papers) and Polyomavirus and related diseases (6 papers). Alden Doyle is often cited by papers focused on Renal Transplantation Outcomes and Treatments (19 papers), Nonmelanoma Skin Cancer Studies (7 papers) and Polyomavirus and related diseases (6 papers). Alden Doyle collaborates with scholars based in United States, United Kingdom and Netherlands. Alden Doyle's co-authors include Roy D. Bloom, Simin Göral, Emily A. Blumberg, Sylvia E. Rosas, Gregory Malat, Kirsten Brukamp, Nancy Bunin, John E. Tomaszewski, Robert Grossman and Karthik Ranganna and has published in prestigious journals such as The Journal of Experimental Medicine, Journal of the American Society of Nephrology and International Journal of Radiation Oncology*Biology*Physics.

In The Last Decade

Alden Doyle

48 papers receiving 1.0k citations

Peers — A (Enhanced Table)

Peers by citation overlap · career bar shows stage (early→late) cites · hero ref

Name h Career Trend Papers Cites
Alden Doyle United States 17 388 299 238 186 180 51 1.0k
E. Renoult France 19 282 0.7× 218 0.7× 334 1.4× 189 1.0× 195 1.1× 67 1.1k
M.A. Gentil Spain 23 702 1.8× 442 1.5× 246 1.0× 169 0.9× 214 1.2× 59 1.3k
Edoardo Melilli Spain 23 622 1.6× 501 1.7× 363 1.5× 200 1.1× 207 1.1× 91 1.5k
Priya S. Verghese United States 15 259 0.7× 160 0.5× 159 0.7× 323 1.7× 107 0.6× 56 842
Vinay Nair United States 14 275 0.7× 133 0.4× 160 0.7× 153 0.8× 98 0.5× 35 843
Marie Matignon France 20 528 1.4× 210 0.7× 257 1.1× 54 0.3× 165 0.9× 62 965
Mark Harber United Kingdom 19 182 0.5× 352 1.2× 84 0.4× 129 0.7× 150 0.8× 53 888
Dolores Redondo‐Pachón Spain 19 630 1.6× 192 0.6× 417 1.8× 111 0.6× 272 1.5× 82 1.2k
Anna Manonelles Spain 16 400 1.0× 307 1.0× 241 1.0× 80 0.4× 227 1.3× 52 974
Joëlle Guitard France 20 613 1.6× 358 1.2× 373 1.6× 160 0.9× 189 1.1× 38 2.2k

Countries citing papers authored by Alden Doyle

Since Specialization
Citations

This map shows the geographic impact of Alden Doyle's research. It shows the number of citations coming from papers published by authors working in each country. You can also color the map by specialization and compare the number of citations received by Alden Doyle with the expected number of citations based on a country's size and research output (numbers larger than one mean the country cites Alden Doyle more than expected).

Fields of papers citing papers by Alden Doyle

Since Specialization
Physical SciencesHealth SciencesLife SciencesSocial Sciences

This network shows the impact of papers produced by Alden Doyle. Nodes represent research fields, and links connect fields that are likely to share authors. Colored nodes show fields that tend to cite the papers produced by Alden Doyle. The network helps show where Alden Doyle may publish in the future.

Co-authorship network of co-authors of Alden Doyle

This figure shows the co-authorship network connecting the top 25 collaborators of Alden Doyle. A scholar is included among the top collaborators of Alden Doyle based on the total number of citations received by their joint publications. Widths of edges represent the number of papers authors have co-authored together. Node borders signify the number of papers an author published with Alden Doyle. Alden Doyle is excluded from the visualization to improve readability, since they are connected to all nodes in the network.

All Works

20 of 20 papers shown
1.
Doyle, Alden, Elizabeth Schiffman, Alex M. Garvin, et al.. (2025). Donor-Derived Ehrlichiosis Caused by Ehrlichia chaffeensis from Living Donor Kidney Transplant. Emerging infectious diseases. 31(3). 587–590. 1 indexed citations
2.
Sifri, Costi D., et al.. (2022). Bartonella Induced Hemophagocytic Lymphohistiocytosis (HLH) in a Kidney Transplant Recipient. Journal of the American Society of Nephrology. 33(11S). 973–973.
3.
Kennedy, Jamie L.W., et al.. (2022). Intensive ultrafiltration strategy restores kidney transplant candidacy for patients with echocardiographic evidence of pulmonary hypertension. Clinical Transplantation. 36(11). e14799–e14799. 3 indexed citations
4.
Bottomley, Matthew J., Paul R. Massey, Raj Thuraisingham, et al.. (2022). Interventions After First Post-Transplant Cutaneous Squamous Cell Carcinoma: A Proposed Decision Framework. Transplant International. 35. 10880–10880. 5 indexed citations
5.
Rao, Swati, Alden Doyle, Amar Ahmad, et al.. (2020). The burden of cutaneous disease in solid organ transplant recipients of color. American Journal of Transplantation. 21(3). 1215–1226. 11 indexed citations
6.
Fernández, Hilda, Sandra Amaral, Pamela A. Shaw, et al.. (2019). The effect of transfer to adult transplant care on kidney function and immunosuppressant drug level variability in pediatric kidney transplant recipients. Pediatric Transplantation. 23(6). 6 indexed citations
7.
Lee, Dong Heun, Gregory Malat, Tiffany E. Bias, et al.. (2019). Safety and Efficacy of Universal Postoperative Decolonization for Kidney Transplant Recipients. Experimental and Clinical Transplantation. 18(2). 153–156. 1 indexed citations
8.
Abdelmalek, Mark, et al.. (2019). Cutaneous disease in solid organ transplant recipients: A 5-year experience from a multidisciplinary medical-surgical transplant dermatology center. Journal of the American Academy of Dermatology. 83(1). 219–221.
9.
Doyle, Alden, et al.. (2018). Evaluation and Management of CKD in the Nonkidney Solid Organ Transplant Recipient. Clinical Journal of the American Society of Nephrology. 13(4). 652–654. 1 indexed citations
10.
Jindal, Rahul M., et al.. (2016). Diabetes, hypertension, sanitation, and health education by high school students in Guyana, South America. Indian Journal of Nephrology. 26(3). 192–192. 4 indexed citations
11.
Sawinski, Deirdre, et al.. (2016). Successful Posttransplant Treatment of Hepatitis C With Ledipasvir-Sofosbuvir in HIV+ Kidney Transplant Recipients. Transplantation. 101(5). 974–979. 12 indexed citations
12.
Cusack, Carrie Ann, et al.. (2014). Vismodegib for Locally Advanced Basal Cell Carcinoma in a Heart Transplant Patient. JAMA Dermatology. 151(1). 70–70. 10 indexed citations
13.
Malat, Gregory, Rahul M. Jindal, Kathan Mehta, et al.. (2014). Kidney Donor Risk Index (KDRI) Fails to Predict Kidney Allograft Survival in HIV (+) Recipients. Transplantation. 98(4). 436–442. 7 indexed citations
14.
Malat, Gregory, et al.. (2012). High Frequency of Rejections in HIV-Positive Recipients of Kidney Transplantation. Transplantation. 94(10). 1020–1024. 31 indexed citations
15.
Al‐Naamani, Nadine, Omar H. Maarouf, Vivek N. Ahya, et al.. (2008). Assessment of Kidney Function in Lung Transplant Candidates. The Journal of Heart and Lung Transplantation. 27(6). 635–641. 9 indexed citations
16.
Göral, Simin, Eline T. Luning Prak, Roy D. Bloom, et al.. (2007). Preformed donor-directed anti-HLA-DP antibodies may be an impediment to successful kidney transplantation. Nephrology Dialysis Transplantation. 23(1). 390–392. 42 indexed citations
17.
Barton, Todd D., Emily A. Blumberg, Alden Doyle, et al.. (2006). A prospective cross‐sectional study of BK virus infection in non‐renal solid organ transplant recipients with chronic renal dysfunction. Transplant Infectious Disease. 8(2). 102–107. 38 indexed citations
18.
19.
Bloom, Roy D. & Alden Doyle. (2006). Kidney Disease After Heart and Lung Transplantation. American Journal of Transplantation. 6(4). 671–679. 95 indexed citations
20.
Sonett, Joshua, et al.. (2002). Trimodality treatment versus surgery alone for esophageal cancer. A stratified analysis with minimally invasive pretreatment staging.. PubMed. 43(4). 531–7. 4 indexed citations

Rankless uses publication and citation data sourced from OpenAlex, an open and comprehensive bibliographic database. While OpenAlex provides broad and valuable coverage of the global research landscape, it—like all bibliographic datasets—has inherent limitations. These include incomplete records, variations in author disambiguation, differences in journal indexing, and delays in data updates. As a result, some metrics and network relationships displayed in Rankless may not fully capture the entirety of a scholar's output or impact.

Explore authors with similar magnitude of impact

Breakdown of academic impact, for papers by E. Renoult Breakdown of academic impact, for papers by M.A. Gentil Breakdown of academic impact, for papers by Edoardo Melilli Breakdown of academic impact, for papers by Priya S. Verghese Breakdown of academic impact, for papers by Vinay Nair Breakdown of academic impact, for papers by Marie Matignon Breakdown of academic impact, for papers by Mark Harber Breakdown of academic impact, for papers by Dolores Redondo‐Pachón Breakdown of academic impact, for papers by Anna Manonelles Breakdown of academic impact, for papers by Joëlle Guitard
Rankless by CCL
2026